Vener8 is a GE global commercialization partner. Through Vener8, accuFD has licensed GE's revolutionary gravity array
separation technology for use in blood sample separation.
By optimizing key fluidic and gravitational principles, accuFD separates blood plasma from cells with > 99% accuracy. Key applications include sample preparation for non-invasive pregnancy testing and liquid biopsies.
accuFD is faster, less expensive, and requires less human intervention than traditional centrifugation and thus offers a superior diagnostic sample preparation solution.
Jody Berry (Director Research, Grifols)
Jerry Culp (VP Global Development, Stryker)
Paul Neeb (CEO, Director)
Jon Glass (CCO, Vener8)
Susan DeCarlo (Controller)
4717 Campus Drive, Suite 700
Kalamazoo, MI 49008
Tel: (269) 544-3013